1. ALLA AKTIER
  2. NYHETER
  3. CINCLUS PHARMA

Cinclus Pharma

Nyheter Cinclus Pharma Nyheter alla bolag

Invitation to presentation of Cinclus Pharma’s fourth quarter report 2024

Cinclus Pharma’s fourth quarter report for October – December 2024 will be published on Thursday, February 20, 2024, at 08:00 am CET. The company will host a live presentation the same day at 10:00 am CET.

The report is presented by CEO Christer Ahlberg and CFO Maria Engström. The presentation includes a Q&A session.

To participate, please follow this link: https://financialhearings.com/event/51346

The report, the presentation and a recorded version of the presentation will also be available on the company's website: https://cincluspharma.com/investors/financial-reports/

For additional information, please contact:

Christer Ahlberg, CEO
Phone: +46 70 675 33 30
e-mail: christer.ahlberg@cincluspharma.com

Charlotte Stjerngren, IR
Phone: +46 70 876 87 87
e-mail: charlotte.stjerngren@cincluspharma.com

About Cinclus Pharma

Cinclus Pharma Holding AB (publ) is a clinical late stage pharma company developing a small molecule for the treatment of gastric acid-related diseases and disorders of the upper gastrointestinal tract. Its drug candidate linaprazan glurate represents a novel class of drugs, Potassium-Competitive Acid Blockers (P‑CAB), and provides a fast-acting control of intragastric pH by a different mechanism of action than proton pump inhibitors (PPIs), with unique capacity to deliver acid control, pH>4, around the clock. For more information, please visit www.cincluspharma.com.

Attachments

Invitation to presentation of Cinclus Pharma’s fourth quarter report 2024

Datum 2025-02-06, kl 08:30
Källa MFN
Bifogade filer
Invitation to presentation of Cinclus Pharma’s fourth quarter report 2024
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.